TipRanks
YaSheng Group (HERB)
OTHER OTC:HERB
US Market

YaSheng Group (HERB) Ratios

20 Followers

YaSheng Group Ratios

HERB's free cash flow for Q2 2023 was $0.34. For the 2023 fiscal year, HERB's free cash flow was decreased by $ and operating cash flow was $0.33. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
3.24 3.24 2.71 2.49 3.34
Quick Ratio
2.55 2.55 2.05 1.82 2.07
Cash Ratio
2.00 2.00 1.55 1.36 1.59
Solvency Ratio
1.38 1.38 1.29 1.23 1.17
Operating Cash Flow Ratio
1.29 1.29 0.96 0.78 1.04
Short-Term Operating Cash Flow Coverage
23.65 23.65 18.82 12.93 2.09
Net Current Asset Value
$ 7.62M$ 7.62M$ 4.84M$ 3.08M$ 4.44M
Leverage Ratios
Debt-to-Assets Ratio
<0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
<0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Capital Ratio
<0.01 <0.01 <0.01 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
0.00 0.00 <0.01 <0.01 <0.01
Financial Leverage Ratio
1.02 1.02 1.02 1.02 1.01
Debt Service Coverage Ratio
32.98 32.98 36.18 27.58 3.21
Interest Coverage Ratio
0.00 0.00 1.37K 1.48K 1.47K
Debt to Market Cap
0.04 0.02 0.21 0.10 0.16
Interest Debt Per Share
<0.01 <0.01 0.01 0.01 0.01
Net Debt to EBITDA
-1.08 -1.08 -0.54 -0.48 -0.40
Profitability Margins
Gross Profit Margin
33.46%33.46%33.31%30.06%28.64%
EBIT Margin
29.81%29.81%33.22%26.41%24.67%
EBITDA Margin
31.72%31.72%35.09%28.02%26.81%
Operating Profit Margin
29.81%29.81%29.62%26.41%24.67%
Pretax Profit Margin
33.42%33.42%33.20%28.55%26.52%
Net Profit Margin
33.42%33.42%33.20%28.55%26.52%
Continuous Operations Profit Margin
33.42%33.42%33.20%28.55%26.52%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
112.08%112.08%112.08%108.09%107.51%
Return on Assets (ROA)
2.78%2.78%2.55%1.98%1.40%
Return on Equity (ROE)
2.92%2.84%2.61%2.01%1.42%
Return on Capital Employed (ROCE)
2.52%2.52%2.31%1.85%1.32%
Return on Invested Capital (ROIC)
2.52%2.52%2.31%1.85%1.31%
Return on Tangible Assets
4.89%4.89%4.66%3.64%2.61%
Earnings Yield
155.58%58.34%72.59%32.72%26.88%
Efficiency Ratios
Receivables Turnover
16.04 16.04 16.56 19.25 14.07
Payables Turnover
23.74 23.74 23.53 22.43 27.21
Inventory Turnover
5.49 5.49 5.49 6.31 3.35
Fixed Asset Turnover
0.16 0.16 0.15 0.14 0.11
Asset Turnover
0.08 0.08 0.08 0.07 0.05
Working Capital Turnover Ratio
2.98 2.98 3.75 3.68 2.40
Cash Conversion Cycle
73.84 73.84 72.98 60.56 121.35
Days of Sales Outstanding
22.76 22.76 22.04 18.96 25.95
Days of Inventory Outstanding
66.45 66.45 66.45 57.87 108.82
Days of Payables Outstanding
15.38 15.38 15.51 16.27 13.41
Operating Cycle
89.22 89.22 88.49 76.83 134.77
Cash Flow Ratios
Operating Cash Flow Per Share
0.03 0.03 0.02 0.02 0.01
Free Cash Flow Per Share
0.02 0.02 0.02 <0.01 0.01
CapEx Per Share
0.02 0.02 <0.01 0.01 <0.01
Free Cash Flow to Operating Cash Flow
0.50 0.50 0.72 0.17 0.79
Dividend Paid and CapEx Coverage Ratio
2.00 2.00 3.59 1.20 4.88
Capital Expenditure Coverage Ratio
2.00 2.00 3.59 1.20 4.88
Operating Cash Flow Coverage Ratio
23.65 23.65 1.84 1.42 1.09
Operating Cash Flow to Sales Ratio
0.23 0.23 0.18 0.13 0.17
Free Cash Flow Yield
52.81%19.80%28.15%2.46%14.03%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
0.64 1.72 1.38 3.06 3.72
Price-to-Sales (P/S) Ratio
0.21 0.57 0.46 0.87 0.99
Price-to-Book (P/B) Ratio
0.02 0.05 0.04 0.06 0.05
Price-to-Free Cash Flow (P/FCF) Ratio
1.89 5.05 3.55 40.72 7.13
Price-to-Operating Cash Flow Ratio
0.94 2.52 2.56 6.76 5.67
Price-to-Earnings Growth (PEG) Ratio
0.01 0.11 0.04 0.05 0.15
Price-to-Fair Value
0.02 0.05 0.04 0.06 0.05
Enterprise Value Multiple
-0.41 0.72 0.76 2.64 3.28
Enterprise Value
-3.11M 5.53M 5.64M 13.73M 12.31M
EV to EBITDA
-0.41 0.72 0.76 2.64 3.28
EV to Sales
-0.13 0.23 0.27 0.74 0.88
EV to Free Cash Flow
-1.14 2.02 2.07 34.47 6.35
EV to Operating Cash Flow
-0.57 1.01 1.50 5.72 5.05
Tangible Book Value Per Share
1.01 1.01 0.92 0.90 0.80
Shareholders’ Equity Per Share
1.81 1.81 1.71 1.68 1.51
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 0.00 0.00 0.00
Revenue Per Share
0.15 0.15 0.13 0.12 0.08
Net Income Per Share
0.05 0.05 0.04 0.03 0.02
Tax Burden
1.00 1.00 1.00 1.00 1.00
Interest Burden
1.12 1.12 1.00 1.08 1.08
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.04 0.04 <0.01 <0.01 <0.01
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
0.68 0.68 0.54 0.45 0.66
Currency in USD